Clinical Trials Directory

Trials / Completed

CompletedNCT07006558

Kinetic Study Of Supplementation With The Enzyme Diamine Oxidase In Patients With Histamine Intolerance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
AB Biotek · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The present study was conducted to assess the safety and tolerability of five ascending doses of plant-based DAO enzyme supplement in subjects with symptoms of histamine intolerance.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDiamino OxidaseThe investigational product is a dehydrated power of DAO enzyme from green pea (Pisum sativum L.) sprouts (adiDAO®Veg, DR Healthcare, S.L.U., Barcelona, Spain), with an enzymatic activity \> 298 mU/g (\> 14,500 kHDU/g).

Timeline

Start date
2023-06-23
Primary completion
2024-08-05
Completion
2024-08-05
First posted
2025-06-05
Last updated
2025-06-18

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07006558. Inclusion in this directory is not an endorsement.

Kinetic Study Of Supplementation With The Enzyme Diamine Oxidase In Patients With Histamine Intolerance (NCT07006558) · Clinical Trials Directory